PhD Candidate Discovers Increasing Risk for Liver Cancer Among US Residents of Mexican DescentJanuary 26th 2023
The risk for developing hepatocellular carcinoma appears to increase with subsequent generations for Americans of Mexican descent, according to findings from a study of US-born Hispanics/Latinos living in Los Angeles, California.
Developing Culturally Concordant Palliative Care for Hindu Patients and FamiliesJanuary 18th 2023
Sometimes, clinicians do not acknowledge how patients' values and beliefs influence how they ascribe meaning to their illness, how they prefer to receive information, and how they make decisions until the end-of-life stage, leading to misunderstandings between clinicians and patients.
Considerations When Treating Patients With Metastatic Renal Cell CarcinomaJanuary 17th 2023
Similar to first-line therapy choices, particular treatment factors, including type and duration of response to prior therapy, pace of disease progression, and toxicities associated with first-line treatment, are all practical considerations that help guide therapy selection in metastatic renal cell carcinoma.
Crane Helps Fellows Navigate a Fraught Time in GynecologyJanuary 10th 2023
Erin K. Crane, MD, MPH, talked to Oncology Fellows about helping trainees care for their own health and wellness, navigate the politics surrounding gynecologic care, and the lessons she hopes they take away from the program.
Seismic Change Occurs in Small BitesJanuary 9th 2023
The Dobbs v Jackson Women’s Health Organization decision, a landmark decision of the US Supreme Court in which the court held that the Constitution of the United States does not confer a right to abortion, will most likely affect your practice.
How to Improve Care for LGBTQI+ Patients With CancerDecember 16th 2022
As more and more people in the United States identify as lesbian, gay, bisexual, transgender, queer, intersex, or other sexual orientation or gender minority, the population of LGBTQI+ cancer survivors is becoming uniquely heterogeneous.
A New Take on Preclinical Drug Trials for Glioblastoma TreatmentDecember 14th 2022
The Ivy Brain Tumor Center at Barrow Neurological Institute in Phoenix, Arizona, is attempting to change the way preclinical studies are developed and conducted to assess the efficacy of drugs for glioblastoma multiforme.